{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:06:52Z","timestamp":1792598812047,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.ijrobp.2013.08.001","type":"journal-article","created":{"date-parts":[[2013,9,21]],"date-time":"2013-09-21T16:47:51Z","timestamp":1379782071000},"page":"738-746","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Volume-Based Parameters of 18F-Fluorodeoxyglucose Positron Emission Tomography\/Computed Tomography Improve Disease Recurrence Prediction in Postmastectomy Breast Cancer Patients With 1 to 3 Positive Axillary Lymph Nodes"],"prefix":"10.1016","volume":"87","author":[{"given":"Naomi","family":"Nakajima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Sugawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiko","family":"Kiyoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shozo","family":"Ohsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruhito","family":"Mochizuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2013.08.001_bib1","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.radonc.2007.02.001","article-title":"Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials","volume":"82","author":"Overgaard","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2013.08.001_bib2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1159\/000333250","article-title":"Should postmastectomy radiotherapy to the chest wall and regional lymph nodes be standard for patients with 1-3 positive lymph nodes?","volume":"6","author":"Offersen","year":"2011","journal-title":"Breast Care (Basel)"},{"key":"10.1016\/j.ijrobp.2013.08.001_bib3","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/S0140-6736(05)67887-7","article-title":"Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials","volume":"366","author":"Clarke","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2013.08.001_bib4","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of ischemic heart disease in women after radiotherapy for breast cancer","volume":"368","author":"Darby","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2013.08.001_bib5","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1200\/JCO.2004.01.042","volume":"22","author":"Taghian","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2013.08.001_bib6","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.ijrobp.2011.10.023","article-title":"Validation that metabolic tumor volume predicts outcome in head-and-neck Cancer","volume":"83","author":"Tang","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2013.08.001_bib7","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1245\/s10434-011-2153-x","article-title":"Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis in\u00a0patients with epithelial ovarian cancer","volume":"19","author":"Chung","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ijrobp.2013.08.001_bib8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00259-011-1934-6","article-title":"Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with\u00a0non-small cell lung cancer","volume":"39","author":"Liao","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ijrobp.2013.08.001_bib9","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.lungcan.2011.01.007","article-title":"Prognostic significance of metabolic parameters measured by (18)F-fluorodeoxyglucose positron emission tomography\/computed tomography in patients with small cell lung cancer","volume":"73","author":"Zhu","year":"2011","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ijrobp.2013.08.001_bib10","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.ygyno.2012.03.021","article-title":"Metabolic tumor volume by (18)F-FDG PET\/CT is prognostic for stage IVB endometrial carcinoma","volume":"125","author":"Liu","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijrobp.2013.08.001_bib11","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s13139-011-0081-0","article-title":"Prognostic value of primary tumor uptake on F-18 FDG PET\/CT in patients with invasive ductal breast cancer","volume":"45","author":"Song","year":"2011","journal-title":"Nucl Med Mol Imaging"},{"key":"10.1016\/j.ijrobp.2013.08.001_bib12","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2967\/jnumed.111.098640","article-title":"18F-FDG uptake by metastatic axillary lymph nodes on pretreatment PET\/CT as a prognostic factor for recurrence in patients with invasive ductal breast cancer","volume":"53","author":"Song","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijrobp.2013.08.001_bib13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.breast.2012.05.009","article-title":"Is [(18)F] fluorodeoxyglucose uptake by the primary tumor a prognostic factor in breast cancer?","volume":"22","author":"De Cicco","year":"2013","journal-title":"Breast"},{"key":"10.1016\/j.ijrobp.2013.08.001_bib14","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/MNM.0b013e328360d945","article-title":"The relationship between 18F-FDG metabolic volumetric parameters and clinicopathological factors of breast cancer","volume":"34","author":"Kaida","year":"2013","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.ijrobp.2013.08.001_bib15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00259-009-1297-4","article-title":"FDG PET and PET\/CT: EANM procedure guidelines for tumour PET imaging: version 1.0","volume":"37","author":"Boellaard","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ijrobp.2013.08.001_bib16","doi-asserted-by":"crossref","first-page":"136","DOI":"10.6004\/jnccn.2011.0016","article-title":"Invasive breast cancer","volume":"9","author":"Carlson","year":"2011","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.ijrobp.2013.08.001_bib17","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1007\/s00259-012-2077-0","article-title":"Whole-body FDG PET\/CT is more accurate than conventional imaging for staging primary breast cancer patients","volume":"39","author":"Riegger","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ijrobp.2013.08.001_bib18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10549-011-1767-9","article-title":"18F-FDG PET\/CT as a staging procedure in primary stage II and III breast cancer: Comparison with conventional imaging techniques","volume":"131","author":"Koolen","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2013.08.001_bib19","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.2967\/jnumed.111.093864","article-title":"The yield of 18F-FDG PET\/CT in patients with clinical stage IIA, IIB, or IIIA breast cancer: A prospective study","volume":"52","author":"Groheux","year":"2011","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijrobp.2013.08.001_bib20","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1634\/theoncologist.2010-0366","article-title":"Different annual recurrence pattern between lumpectomy and mastectomy: Implication for breast cancer surveillance after breast-conserving surgery","volume":"16","author":"Yu","year":"2011","journal-title":"Oncologist"},{"key":"10.1016\/j.ijrobp.2013.08.001_bib21","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1200\/JCO.1996.14.10.2738","article-title":"Annual hazard rates of recurrence for breast cancer after primary therapy","volume":"14","author":"Saphner","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2013.08.001_bib22","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10549-008-0023-4","article-title":"Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: A meta-analysis","volume":"114","author":"Lu","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2013.08.001_bib23","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1177\/030089160409000302","article-title":"Early detection of recurrences in the follow-up of primary breast cancer in an asymptomatic or symptomatic phase","volume":"90","author":"Perrone","year":"2004","journal-title":"Tumori"},{"key":"10.1016\/j.ijrobp.2013.08.001_bib24","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.2967\/jnumed.110.075721","article-title":"The XbaI G>T polymorphism of the glucose transporter 1 gene modulates 18F-FDG uptake and tumor aggressiveness in breast cancer","volume":"51","author":"Grabellus","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijrobp.2013.08.001_bib25","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.2967\/jnumed.111.101733","article-title":"Noise considerations for PET quantification using maximum and peak standardized uptake value","volume":"53","author":"Lodge","year":"2012","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.ijrobp.2013.08.001_bib26","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s00259-010-1640-9","article-title":"Correlation of high 18F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer","volume":"38","author":"Groheux","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ijrobp.2013.08.001_bib27","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/jjco\/hyn019","article-title":"Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography\/computed tomography fusion imaging (18F-FDG PET\/CT) in primary breast cancer","volume":"38","author":"Ueda","year":"2008","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2013.08.001_bib28","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1007\/s00259-010-1529-7","article-title":"FDG PET\/CT and diffusion-weighted imaging for breast cancer: Prognostic value of maximum standardized uptake values and apparent diffusion coefficient values of\u00a0the primary lesion","volume":"37","author":"Nakajo","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ijrobp.2013.08.001_bib29","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1177\/000313480707301116","article-title":"Standardized uptake values for breast carcinomas assessed by fluorodeoxyglucose-positron emission tomography correlate with prognostic factors","volume":"73","author":"Ikenaga","year":"2007","journal-title":"Am Surg"},{"key":"10.1016\/j.ijrobp.2013.08.001_bib30","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s10147-010-0120-3","article-title":"Value of PET-FDG in primary breast cancer based on histopathological and immunohistochemical prognostic factors","volume":"15","author":"Heudel","year":"2010","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2013.08.001_bib31","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/1471-2407-10-228","article-title":"Use of ER\/PR\/HER2 subtypes in conjunction with the 2007 St Gallen Consensus Statement for early breast cancer","volume":"10","author":"Bauer","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijrobp.2013.08.001_bib32","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/annonc\/mdm271","article-title":"Progress and promise: Highlights of the international expert consensus on the primary therapy of early breast cancer 2007","volume":"18","author":"Goldhirsch","year":"2007","journal-title":"Ann Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030161302957X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030161302957X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:41:17Z","timestamp":1759743677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036030161302957X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S036030161302957X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2013.08.001","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Volume-Based Parameters of 18F-Fluorodeoxyglucose Positron Emission Tomography\/Computed Tomography Improve Disease Recurrence Prediction in Postmastectomy Breast Cancer Patients With 1 to 3 Positive Axillary Lymph Nodes","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2013.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}